Cite

HARVARD Citation

    Saito, N. et al. (2022). A case of unresectable combined hepatocellular and cholangiocarcinoma treated with atezolizumab plus bevacizumab. Clinical case reports. 10 (7), p. n/a. [Online]. 
  
Back to record